Clinical Trial Update: Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of GSK1278863 in Japanese hemodialysis patients with anemia due to chronic kidney disease not on erythropoiesis-stim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 3 | Status: COMPLETED | Results posted: 2018-07-13